| 000 | 01581 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513200205.0 | ||
| 264 | 0 | _c20000127 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0162-3109 | ||
| 024 | 7 |
_a10.1016/s0162-3109(99)00128-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPruneau, D | |
| 245 | 0 | 0 |
_aPharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist. _h[electronic resource] |
| 260 |
_bImmunopharmacology _cSep 1999 |
||
| 300 |
_a187-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aBlood-Brain Barrier |
| 650 | 0 | 4 | _aBradykinin Receptor Antagonists |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInositol Phosphates _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aQuinolines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReceptor, Bradykinin B2 |
| 700 | 1 | _aPaquet, J L | |
| 700 | 1 | _aLuccarini, J M | |
| 700 | 1 | _aDefrêne, E | |
| 700 | 1 | _aFouchet, C | |
| 700 | 1 | _aFranck, R M | |
| 700 | 1 | _aLoillier, B | |
| 700 | 1 | _aRobert, C | |
| 700 | 1 | _aBélichard, P | |
| 700 | 1 | _aDuclos, H | |
| 700 | 1 | _aCremers, B | |
| 700 | 1 | _aDodey, P | |
| 773 | 0 |
_tImmunopharmacology _gvol. 43 _gno. 2-3 _gp. 187-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0162-3109(99)00128-9 _zAvailable from publisher's website |
| 999 |
_c10552925 _d10552925 |
||